Gedeon Richter (Uk) Limited

Gedeon Richter (Uk) Limited company information, Employees & Contact Information

Gedeon Richter is a global women’s healthcare company focused on developing products that support women throughout their life course. With more than 120 years of experience internationally - and an extensive capacity in research and development – Gedeon Richter is continuously adjusting to meet the needs of women and healthcare professionals. Gedeon Richter is one of the few companies in the world to offer a comprehensive women’s health portfolio and our research and development team continue to innovate and extend our gynaecological, fertility and osteoporosis range. We know that when women are in control of their own health, they can focus on achieving what they want out of life. Our ambition is to help women achieve theirs. Since opening our UK Affiliate we have worked with healthcare systems across the country, striving to deliver choice and innovation for women. Follow us on LinkedIn today to keep up to date with what we get up to in the UK. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/, or you can report via the Yellow Card app which is available to download from the Apple App Store or Google Play Store. Adverse events should also be reported to Gedeon Richter (UK) Ltd on +44 (0) 207 604 8806 or by email to drugsafety.uk@gedeonrichter.eu UK-WOM-2300047, September 2023

Company Details

Employees
56
Founded
-
Address
127 Shirland Road, Maida Vale,london,england W9 2ep,united Kingdom
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Maida Vale, London, England
Looking for a particular Gedeon Richter (Uk) Limited employee's phone or email?

Gedeon Richter (Uk) Limited Questions

News

Gedeon Richter launches Nalvee in UK to expand HRT options for menopause - PharmaTimes

Gedeon Richter launches Nalvee in UK to expand HRT options for menopause PharmaTimes

Gedeon Richter’s once-daily endometriosis pill approved for NHS use - Pharmaceutical Technology

Gedeon Richter’s once-daily endometriosis pill approved for NHS use Pharmaceutical Technology

Gedeon Richter brings HRT option back to the UK market - pharmaphorum

Gedeon Richter brings HRT option back to the UK market pharmaphorum

Gedeon Richter launches Nalvee in UK - The Pharma Letter

Gedeon Richter launches Nalvee in UK The Pharma Letter

Adalvo And Gedeon Richter Join Forces On Semaglutide - Citeline News & Insights

Adalvo And Gedeon Richter Join Forces On Semaglutide Citeline News & Insights

NHS approves long-term daily pill for endometriosis in England - Clinical Trials Arena

NHS approves long-term daily pill for endometriosis in England Clinical Trials Arena

"Gedeon Richter House of Hope" opens its doors to support 300 women annually in Africa-Bamako - Adnkronos

"Gedeon Richter House of Hope" opens its doors to support 300 women annually in Africa-Bamako Adnkronos

NHS contraceptive pills funding Orban ‘propaganda’ as Hungary restricts abortion - The Ferret

NHS contraceptive pills funding Orban ‘propaganda’ as Hungary restricts abortion The Ferret

NICE recommends first oral GnRH antagonist for uterine fibroids - European Pharmaceutical Review

NICE recommends first oral GnRH antagonist for uterine fibroids European Pharmaceutical Review

Marketing authorisation acquired for first and only transdermal contraceptive patch in UK - PharmaTimes

Marketing authorisation acquired for first and only transdermal contraceptive patch in UK PharmaTimes

Gedeon Richter: Cariprazine is well tolerated in the early stage of schizophrenia and has a positive effect on engagement compared to another antipsychotic - PR Newswire UK

Gedeon Richter: Cariprazine is well tolerated in the early stage of schizophrenia and has a positive effect on engagement compared to another antipsychotic PR Newswire UK

Levosert® (52mg levonorgestrel intrauterine system [IUS]) receives an 8-year licence extension in the UK for contraception - Pharmafile

Levosert® (52mg levonorgestrel intrauterine system [IUS]) receives an 8-year licence extension in the UK for contraception Pharmafile

Gedeon Richter plc v Bayer Schering Pharma AG [2012] EWCA Civ 235 - Wolters Kluwer

Gedeon Richter plc v Bayer Schering Pharma AG [2012] EWCA Civ 235 Wolters Kluwer

Gedeon Richter falls foul of ABPI - PMLiVE

Gedeon Richter falls foul of ABPI PMLiVE

Gedeon Richter launches Vagirux 10mcg for vaginal atrophy - Chemist+Druggist

Gedeon Richter launches Vagirux 10mcg for vaginal atrophy Chemist+Druggist

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids - Pf Media

MHRA licenses Gedeon Richter’s Ryeqo for symptoms of uterine fibroids Pf Media

Gedeon Richter announces availability of oral contraception Drovelis - PharmaTimes

Gedeon Richter announces availability of oral contraception Drovelis PharmaTimes

Gedeon Richter: Cariprazine has no significant interaction with combined hormonal contraceptives - PR Newswire UK

Gedeon Richter: Cariprazine has no significant interaction with combined hormonal contraceptives PR Newswire UK

MHRA licenses endometriosis treatment for patients in the UK - Pf Media

MHRA licenses endometriosis treatment for patients in the UK Pf Media

Top Gedeon Richter (Uk) Limited Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant